We are live on ! Find out more
VNRX icon

VolitionRx Ltd

36 hedge funds and large institutions have $18.7M invested in VolitionRx Ltd in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% less ownership

Funds ownership: 0.58%0.56% (-0.03%)

3% less capital invested

Capital invested by funds: $19.2M → $18.7M (-$493K)

8% less funds holding

Funds holding: 3936 (-3)

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

60% less call options, than puts

Call options by funds: $105K | Put options by funds: $262K

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
11
Closed
5
Calls
$105K
Puts
$262K
Net Calls
-$157K
Net Calls Change
+$73K

VNRX Hedge Fund Activity: Q4 2021 in Review

36 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2021, worth a combined $18.7M — down 2.6% from $19.2M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VNRX and 3 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 7 added.

The largest buyer was Lagoda Investment Management, adding an estimated $821K. The largest seller was Ergoteles, cutting an estimated $403K.

  • 36 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2021, down from 39 in Q3 2021.
  • Funds reported $18.7M of VolitionRx Ltd stock for Q4 2021, down 2.6% quarter-over-quarter.
  • 3 funds opened new VolitionRx Ltd positions in Q4 2021 and 5 closed out, a net change of -2 holders.
  • The largest VolitionRx Ltd buyer in Q4 2021 was Lagoda Investment Management, an estimated $821K added.
  • The largest VolitionRx Ltd seller in Q4 2021 was Ergoteles, an estimated $403K sold.

Based on aggregated 13F filings for Q4 2021.